← All tickers

Is KURA Worth Buying in 2026?

Kura Oncology, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Kura Oncology, Inc. (KURA) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 58 — healthy momentum range; strong 1-year return of +64.5%; 3-month momentum positive (+17.8%). Concerns: 50-day MA is falling (-0.55% over 10 days). Currently 13.1% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

KURA is in a confirmed uptrend, trading above both its 50-day ($10.15) and 200-day ($9.64) moving averages. An RSI of 58.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +64.5% compares to +20.4% for SPY (beat the market by 44.2%).

$10,000 invested 1 year ago → $16,455 today
vs. S&P 500 (SPY) — same period beat market by 44.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($9.64)
✓Above 50-day MA ($10.15)
✓RSI(14) neutral zone (30–70) — currently 58.3
✓Positive return (+64.5%)
!Within 10% of period high (−13.1%)
Period Range $10.86
$6.35 $12.49
RSI (14) 58.3
0 · OversoldOverbought · 100

Key Metrics

Price$10.86
Period Return+64.5%
Period High$12.49
Period Low$6.35
Drawdown−13.1%
MA-50$10.15
MA-200$9.64
RSI (14)58.3
Avg Volume (30d)1.4M
vs. SPYbeat by 44.2%
Return Rank#226 of 1252

Trade KURA

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers